Atlas Trials

Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac Injury

Clinical trial NCT05411705 · UNKNOWN

Trial details

NCT number
NCT05411705
Sponsor
The First Affiliated Hospital of Dalian Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Cancer Treatment Induced Thrombocytopenia
Start date
2022-06-06
Primary completion
2024-06-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.